SFI
KALA icon

Susquehanna Fundamental Investments’s KALA BIO KALA Stock Holding History

Susquehanna Fundamental Investments’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed -$4K – 1348
2022
Q3 		$4K Buy
+7
New +$5.5K ﹤0.01% 1425
2022
Q1 		$108K Sell
31
-8
-21% -$21K ﹤0.01% 1442
2021
Q4 		$119K Sell
39
-9
-19% -$41.8K ﹤0.01% 1318
2021
Q3 		$316K Buy
48
+37
+336% +$319K 0.01% 1386
2021
Q2 		$151K Buy
+11
New +$173K ﹤0.01% 1529
2020
Q3 		– Sell
-7
Closed -$173K – 1366
2020
Q2 		$173K Buy
+7
New +$198K 0.01% 852

Other funds holding KALA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna Fundamental Investments's KALA Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of KALA BIO (KALA) in Q4 2022, closing a stake of 7 shares — an estimated $4K sold.

Susquehanna Fundamental Investments first reported a position in KALA in Q2 2020 and held it in 6 quarters. The position peaked at $316K in Q3 2021. 28 funds tracked by Wall St. Rank hold KALA as of Q4 2022.

  • Susquehanna Fundamental Investments reported no remaining KALA BIO position as of Q4 2022 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 7 KALA BIO shares in Q4 2022, an estimated $4K.
  • Susquehanna Fundamental Investments first reported a position in KALA BIO in Q2 2020 and held it in 6 quarters.
  • Susquehanna Fundamental Investments's KALA BIO position peaked at $316K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.